Now More Than Ever, We Need to Focus on Clinical Trial Participation : Oncology Times
An abstract is unavailable.
Related Articles
Study Highlights Global Trends in Risk Factors Linked to Lung Cancer Deaths – InventUM
A new study by Sylvester researchers used trends in tracheal, bronchial and lung cancer deaths to emphasize the need for policy vigilance.
Advancing Cell Therapy Research, Discovery & Innovation : Oncology Times
An abstract is unavailable.
Study by Sylvester, Collaborators Highlights Global Trends in Risk Factors Linked to Lung Cancer Deaths | Newswise
Lung and related cancer deaths decreased in the world’s 10 most populous countries over the past 40 years, but there is still a pressing need…
Risk Factors for Postoperative Shoulder Imbalance in… : Spine
nd Data. PSI in scoliosis affects patient quality of life. While other correction methods have reported a high correction rate for the main thoracic curve…
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response
Key PointsAdding navitoclax to ongoing ruxolitinib demonstrates durable responses and potential disease modification in relapsed/refractory MF.Thrombocytop
Elon Musk Sets His Sights on Toppling Another World Leader
Not satisfied with what he’s done to America, the world’s richest man is now looking to interfere in a European country.
At least 5 dead as thousands flee raging wildfires in Los Angeles area: Live updates | CNN
Massive wind-driven fires in Los Angeles County have killed at least five people and left others with “significant injuries.” Follow for live updates.
Development and validation of a home quantitative sensory… : PAIN
research and clinical care. The objective of this study was to develop a home QST (HQST) tool-kit that is cost-effective, easy to use, and detects…
